Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
307 participants
OBSERVATIONAL
2010-03-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
NCT01415154
Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents
NCT02586688
An Open Label Trial of TMS Therapy for Bipolar Depression
NCT02640950
Treatment of Major Depressive Disorder in the UK Using TMS Therapy
NCT04217837
Retrospective TMS Therapy for Adults With MDD
NCT05541302
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Neuronetics
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Demitrack, MD
Role: STUDY_DIRECTOR
Neuronetics, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lee Ann Kelley, M.D., PC
Phoenix, Arizona, United States
Bay Psychiatric Associates
Berkeley, California, United States
TMS Center of Beverly Hills
Beverly Hills, California, United States
Clinical Training & Research Institute
Burlingame, California, United States
Sacramento TMS
El Dorado Hills, California, United States
Martha Koo, MD
Hermosa Beach, California, United States
Orange County TMS Center
Laguna Hills, California, United States
Depression Research Center and Clinic-Semel Institute for Neuroscience & Human Behavior at UCLA
Los Angeles, California, United States
Kevin Kinback, MD
Mission Viejo, California, United States
Todd Hutton, MD & Associates
Pasadena, California, United States
The Botkiss Center for TMS Therapy
San Diego, California, United States
Stanford Hospital and Clinics
Stanford, California, United States
Arjun Reyes, MD
Woodland Hills, California, United States
Hartford Hospital
Hartford, Connecticut, United States
Comprehensive Psychiatric Care
Norwich, Connecticut, United States
Christiana Care Health Services
Wilmington, Delaware, United States
Health Sciences America, LLC
Boca Raton, Florida, United States
Curtis Cassidy, MD
Lakeland, Florida, United States
Brian Teliho, MD
Atlanta, Georgia, United States
Carl M. Wahlstrom, Jr. MD Limited
Chicago, Illinois, United States
Northwestern Medical Faculty Foundation
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Brain Stimulation Chicago North Shore
Northbrook, Illinois, United States
Behavioral Health Care Associates
Schaumburg, Illinois, United States
University Psychiatric Foundation
Louisville, Kentucky, United States
Integrative Psychiatry
Louisville, Kentucky, United States
Spectrum Behavioral Health
Annapolis, Maryland, United States
Sheppard Pratt Health System
Baltimore, Maryland, United States
Anthony Drobnick, MD
Saint Michaels, Maryland, United States
Newton-Wellesley Psychiatry
Newton, Massachusetts, United States
Central Psychiatry
Las Vegas, Nevada, United States
TMS Center of New England
Portsmouth, New Hampshire, United States
Santa Fe TMS Therapy Center
Santa Fe, New Mexico, United States
Dent Neurosciences Research Center, Inc.
Amherst, New York, United States
The TMS Institute of Pennsylvania-Advanced Neuropsychiatric Solutions
West Chester, Pennsylvania, United States
Butler Hospital
Providence, Rhode Island, United States
W. Scott West, M.D.
Nashville, Tennessee, United States
Texas Neuropsychiatric Institute
Amarillo, Texas, United States
Texas TMS Center at Senior Adults Specialty Healthcare (SASH)
Austin, Texas, United States
Houston TMS
Houston, Texas, United States
Agape Mind Services/The Costello Clinic
Lewisville, Texas, United States
Serenity Center for Depression, P.A.
Sugar Land, Texas, United States
University Neuropsychiatric Institute
Salt Lake City, Utah, United States
Center for Anxiety and Depression
Mercer Island, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dunner DL, Aaronson ST, Sackeim HA, Janicak PG, Carpenter LL, Boyadjis T, Brock DG, Bonneh-Barkay D, Cook IA, Lanocha K, Solvason HB, Demitrack MA. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry. 2014 Dec;75(12):1394-401. doi: 10.4088/JCP.13m08977.
Janicak PG, Dunner DL, Aaronson ST, Carpenter LL, Boyadjis TA, Brock DG, Cook IA, Lanocha K, Solvason HB, Bonneh-Barkay D, Demitrack MA. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice. CNS Spectr. 2013 Dec;18(6):322-32. doi: 10.1017/S1092852913000357. Epub 2013 Jul 30.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-50001-000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.